Literature DB >> 30682374

A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization.

Miguel F Sanmamed, Lieping Chen.   

Abstract

Year:  2019        PMID： 30682374     DOI： 10.1016/j.cell.2019.01.008

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  33 in total

1.  Prognostic significance of controlling nutritional status score-based nomogram for hepatocellular carcinoma within Milan criteria after radiofrequency ablation.

Authors:  Yi Yang; Feng Ye; Yujing Xin; Yanan Wang; Xiao Li; Duiping Feng; Yi Chen; Xiang Zhou
Journal:  J Gastrointest Oncol       Date:  2020-10

Review 2.  Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy.

Authors:  Lin Tian; Anhua Lei; Tianyu Tan; Mengmeng Zhu; Li Zhang; Haibo Mou; Jin Zhang
Journal:  Kidney Dis (Basel)       Date:  2021-09-28

Review 3.  The chemical biology of IL-12 production via the non-canonical NFkB pathway.

Authors:  Peter D Koch; Mikael J Pittet; Ralph Weissleder
Journal:  RSC Chem Biol       Date:  2020-07-22

Review 4.  Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy.

Authors:  Yang Liu; Pan Zheng
Journal:  Trends Pharmacol Sci       Date:  2019-12-10       Impact factor: 14.819

5.  The interplay between cholesterol (and other metabolic conditions) and immune-checkpoint immunotherapy: shifting the concept from the "inflamed tumor" to the "inflamed patient".

Authors:  Melissa Bersanelli; Alessio Cortellini; Sebastiano Buti
Journal:  Hum Vaccin Immunother       Date:  2021-01-10       Impact factor: 3.452

Review 6.  Developmental pathways of myeloid-derived suppressor cells in neoplasia.

Authors:  Scott I Abrams
Journal:  Cell Immunol       Date:  2020-12-16       Impact factor: 4.868

7.  Toward a Better Understanding of Immune Checkpoint Inhibitor Radiolabeled PET Imaging Studies.

Authors:  Harm Westdorp; Sarah R Verhoeff; Martin Gotthardt; Carla M L van Herpen; Michel M van; den Heuvel; Sandra Heskamp; Erik H J G Aarntzen
Journal:  J Nucl Med       Date:  2022-01-20       Impact factor: 10.057

8.  Hijacking antibody-induced CTLA-4 lysosomal degradation for safer and more effective cancer immunotherapy.

Authors:  Yan Zhang; Xuexiang Du; Mingyue Liu; Fei Tang; Peng Zhang; Chunxia Ai; James K Fields; Eric J Sundberg; Olga S Latinovic; Martin Devenport; Pan Zheng; Yang Liu
Journal:  Cell Res       Date:  2019-07-02       Impact factor: 25.617

Review 9.  Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses.

Authors:  Xi Chen; Xiaohui Pan; Wenxin Zhang; Hongjie Guo; Shuyuan Cheng; Qiaojun He; Bo Yang; Ling Ding
Journal:  Acta Pharm Sin B       Date:  2019-09-25       Impact factor: 11.413

10.  Intelligent Molybdenum Disulfide Complexes as a Platform for Cooperative Imaging-Guided Tri-Mode Chemo-Photothermo-Immunotherapy.

Authors:  Wei Hu; Tingting Xiao; Du Li; Yu Fan; Lingxi Xing; Xipeng Wang; Yulin Li; Xiangyang Shi; Mingwu Shen
Journal:  Adv Sci (Weinh)       Date:  2021-06-18       Impact factor: 16.806
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.